Incyte (INCY) shares have shown solid momentum over the past month, gaining 12% and delivering a 21% return over the past 3 months. The company continues to draw investor attention for its performance ...

Jefferies analyst Kelly Shi maintained a Buy rating on Incyte today and set a price target of $120.00. Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest ...

We recently published Wall Street Can’t Keep up With These 10 Crushing Stocks; 6 at Fresh Record Highs. Incyte Corp. (NASDAQ:INCY) is one of the best-performing on Monday. Incyte extended its winning ...

Greetings, and welcome to the Incyte Third Quarter 2025 Earnings Conference Call webcast [Operator Instructions]. As a reminder, this conference is being recorded. It's now my pleasure to turn the ...

We recently published 11 Best Cancer Stocks to Buy Right Now. Incyte Corporation stands fourth on our list. Incyte Corporation (NASDAQ:INCY) is a biopharmaceutical company focused on cancer and ...

Fintel reports that on August 6, 2025, Wells Fargo upgraded their outlook for Incyte (NasdaqGS:INCY) from Equal-Weight to Overweight. Analyst Price Forecast Suggests 6.78% Upside As of August 6, 2025, ...

Once upon a time, I observed that the storyline of Ultimate Spider-Man was a reverse of the original Spider-Man story in new and interesting, and not totally obvious ways. Specicialy that of "with ...

Click to share on X (Opens in new window) X Click to share on Facebook (Opens in new window) Facebook The books and cartoons were fantastical adventure series that took place in a subterranean world ...

Fintel reports that on March 18, 2025, William Blair downgraded their outlook for Incyte (NasdaqGS:INCY) from Outperform to Market Perform. Analyst Price Forecast Suggests 28.39% Upside As of March 4, ...

Greetings, and welcome to the Incyte Fourth Quarter 2024 and Full Year Financial and Corporate Update Conference Call and Webcast. At this time all participants are in listen-only mode. [Operator ...